Filter posts

Pharmaceuticals Play a Key Role in Value-Based Care

By Dan Leonard, President, National Pharmaceutical Council Public and private sector health care stakeholders have …

Perspective on Market Valuation for Biotech Drug Developers

Of the 300 publicly traded U.S. biotechs, 219 (73%) are developing drugs. The other 27% …

BioCentury TV at BIO International Convention

BioCentury TV interviewed biotech leaders throughout the recent BIO International Convention in Washington, DC. The …

Three dealmaking trends to look for in 2011

The relationship between the biotechnology and pharmaceutical industries has never been clearer – partner to …